Cargando…
Entrapment of an EGFR inhibitor into nanostructured lipid carriers (NLC) improves its antitumor activity against human hepatocarcinoma cells
BACKGROUND: In hepatocellular carcinoma (HCC), different signaling pathways are de-regulated, and among them, the expression of the epidermal growth factor receptor (EGFR). Tyrphostin AG-1478 is a lipophilic low molecular weight inhibitor of EGFR, preferentially acting on liver tumor cells. In order...
Autores principales: | Bondì, Maria Luisa, Azzolina, Antonina, Craparo, Emanuela Fabiola, Botto, Chiara, Amore, Erika, Giammona, Gaetano, Cervello, Melchiorre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033685/ https://www.ncbi.nlm.nih.gov/pubmed/24886097 http://dx.doi.org/10.1186/1477-3155-12-21 |
Ejemplares similares
-
Correction to: Entrapment of an EGFR inhibitor into nanostructured lipid carriers (NLC) improves its antitumor activity against human hepatocarcinoma cells
por: Di Gesù, Roberto, et al.
Publicado: (2018) -
Effects in cigarette smoke stimulated bronchial epithelial cells of a corticosteroid entrapped into nanostructured lipid carriers
por: Bondì, Maria Luisa, et al.
Publicado: (2014) -
Development of New Targeted Inulin Complex Nanoaggregates for siRNA Delivery in Antitumor Therapy
por: Cavallaro, Gennara, et al.
Publicado: (2021) -
Biomedical Applications of Polylactide (PLA) and Its Copolymers
por: Giammona, Gaetano, et al.
Publicado: (2018) -
Polymer-Based Systems for Controlled Release and Targeting of Drugs
por: Giammona, Gaetano, et al.
Publicado: (2019)